XML 43 R27.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Share-based Compensation | 12 Months Ended
--- | ---
Feb. 03, 2018
Share-based Compensation [Abstract] |
Share-based Compensation | Share-based Compensation Plan Summary In 2015, the Company's shareholders approved the 2015 Stock Option and Performance Incentive Plan ("2015 Plan"). The 2015 plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, performance-based restricted stock, performance units and unrestricted shares. The Company grants stock options at a price equal to the fair market value of the stock on the date of grant. Stock options have a maximum term of 10 years. Stock options generally vest ratably over 3 to 5 years. Restricted stock generally vests (the restrictions lapse) at the end of a three-year period or on a graded basis over a five-year period. Under the Company’s plans, approximately 160 million options, restricted and unrestricted shares have been authorized to be granted to employees and directors. Approximately 12 million options and shares were available for grant as of February 3, 2018. From time to time the Company's Board of Directors will declare special dividends. For additional information, see Note 19, "Shareholders' Equity (Deficit)." In accordance with the anti-dilutive provisions of the stock plan, in these circumstances the Company adjusts both the exercise price and the number of share-based awards outstanding as of the record date of the special dividends. The aggregate fair value, the aggregate intrinsic value and the ratio of the exercise price to the market price are approximately equal immediately before and after the adjustments. Therefore, no compensation expense is recognized. Stock Options The following table provides the Company’s stock option activity for the fiscal year ended February 3, 2018:
| Number of Shares |  | Weighted Average Option Price Per Share |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value
| (in thousands) |  |  |  | (in years) |  | (in thousands)
Outstanding as of January 28, 2017 | 5,439 |  |  | $ | 47.17 |  |  |  |  |
Granted | 1,163 |  |  | 47.12 |  |  |  |  |
Exercised | (1,845 | ) |  | 20.70 |  |  |  |  |
Cancelled | (285 | ) |  | 63.62 |  |  |  |  |
Outstanding as of February 3, 2018 | 4,472 |  |  | $ | 57.03 |  |  | 6.53 |  | $ | 18,313 |
Vested and Expected to Vest as of February 3, 2018 (a) | 4,316 |  |  | 57.03 |  |  | 6.44 |  | 18,265 |
Options Exercisable as of February 3, 2018 | 2,202 |  |  | 50.05 |  |  | 4.72 |  | 17,489 |
________________
(a) | The number of options expected to vest includes an estimate of expected forfeitures.
Intrinsic value for stock options is the difference between the current market value of the Company’s stock and the option strike price. The total intrinsic value of options exercised was $44 million for 2017, $30 million for 2016 and $63 million for 2015. The total fair value at grant date of option awards vested was $10 million for 2017 and 2016, and $11 million for 2015. The Company’s total unrecognized compensation cost, net of estimated forfeitures, related to nonvested options was $14 million as of February 3, 2018. This cost is expected to be recognized over a weighted-average period of 2.6 years. The weighted-average estimated fair value of stock options granted was $5.96 per share for 2017, $11.72 per share for 2016 and $15.27 per share for 2015. Cash received from stock options exercised was $38 million for 2017, $20 million for 2016 and $33 million for 2015. Tax benefits realized from tax deductions associated with stock options exercised were $16 million for 2017, $9 million for 2016 and $20 million for 2015. The Company uses the Black-Scholes option-pricing model for valuation of options granted to employees and directors. The Company’s determination of the fair value of options is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the awards and projected employee stock option exercise behaviors. The following table contains the weighted-average assumptions used during 2017, 2016 and 2015:
| 2017 |  | 2016 |  | 2015
Expected Volatility | 28 | % |  | 25 | % |  | 26 | %
Risk-free Interest Rate | 1.5 | % |  | 1.1 | % |  | 1.1 | %
Dividend Yield | 5.1 | % |  | 3.3 | % |  | 2.7 | %
Expected Life (in years) | 3.0 |  |  | 4.1 |  |  | 4.5 |
The majority of the Company’s stock-based compensation awards are granted on an annual basis in the first quarter of each year. The expected volatility assumption is based on the Company’s analysis of historical volatility. The risk-free interest rate assumption is based upon the average daily closing rates during the period for U.S. treasury notes that have a life which approximates the expected life of the option. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts in relation to the stock price at the grant date. The expected life of employee stock options represents the weighted-average period the stock options are expected to remain outstanding. Restricted Stock The following table provides the Company’s restricted stock activity for the fiscal year ended February 3, 2018:
| Number of Shares |  | Weighted Average Grant Date Fair Value
| (in thousands) |  |
Unvested as of January 28, 2017 | 5,292 |  |  | $ | 64.14 |
Granted | 2,571 |  |  | 39.21 |
Vested | (1,800 | ) |  | 48.48 |
Cancelled | (364 | ) |  | 62.09 |
Unvested as of February 3, 2018 | 5,699 |  |  | 57.97 |
The Company’s total intrinsic value of restricted stock vested was $86 million for 2017, $140 million for 2016 and $217 million for 2015. The Company’s total fair value at grant date of awards vested was $87 million for 2017, $68 million for 2016 and $80 million for 2015. Fair value of restricted stock awards is based on the market value of an unrestricted share on the grant date adjusted for anticipated dividend yields. As of February 3, 2018, there was $134 million of total unrecognized compensation cost, net of estimated forfeitures, related to unvested restricted stock. That cost is expected to be recognized over a weighted-average period of 2.6 years. The weighted-average estimated fair value of restricted stock granted was $39.21 per share for 2017, $75.09 per share for 2016 and $85.61 per share for 2015. Tax benefits realized from tax deductions associated with restricted stock vested were $32 million for 2017, $61 million for 2016 and $82 million for 2015. Income Statement Impact The following table provides share-based compensation expense included in the Consolidated Statements of Income for 2017, 2016 and 2015:
| 2017 |  | 2016 |  | 2015
| (in millions)
Costs of Goods Sold, Buying and Occupancy | $ | 32 |  |  | $ | 31 |  |  | $ | 27 |
General, Administrative and Store Operating Expenses | 70 |  |  | 65 |  |  | 70 |
Total Share-based Compensation Expense | $ | 102 |  |  | $ | 96 |  |  | $ | 97 |
Share-based compensation expense is based on awards that are ultimately expected to vest. The Company estimates forfeitures at the time of grant and adjusts, if necessary, in subsequent periods based on historical experience and expected future termination rates. The tax benefit associated with recognized share-based compensation expense was $23 million for 2017, $32 million for 2016 and $33 million for 2015.

X
- Definition Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration